The epidemiology of urinary tract infection

Nature Reviews Urology

Volumn 7, Issue 12, 2010, Pages 653-660

  Foxman, Betsy ^a  

^a UNIVERSITY OF MICHIGAN SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADHESIN; ANTIBIOTIC AGENT; BACTERIAL TOXIN; CIPROFLOXACIN; IBUPROFEN; PIVMECILLINAM; SIDEROPHORE; WATER;

ANTIBIOTIC RESISTANCE; BACTERIAL COLONIZATION; BACTERIAL INFECTION; BACTERIAL TRANSMISSION; BACTERIOLOGY; BACTERIURIA; COMMENSAL; FOOD; HUMAN; INTESTINE FLORA; MORBIDITY; NONHUMAN; PRIORITY JOURNAL; REVIEW; URINARY TRACT INFECTION; UROPATHOGENIC ESCHERICHIA COLI; VAGINA FLORA;

DRUG RESISTANCE, BACTERIAL; HUMANS; INCIDENCE; PREVALENCE; URINARY TRACT INFECTIONS;

EID: 78650106014     PISSN: 17594812     EISSN: 17594820     Source Type: Journal    
DOI: 10.1038/nrurol.2010.190     Document Type: Review

References (63)

1. Rubin, R. H., Shapiro, E. D., Andriole, V. T., Davis, R. J. & Stamm, W. E. Evaluation of new anti-infective drugs for the treatment of urinary tract infectioN. Infectious Diseases Society of America and the Food and Drug AdministratioN. CliN. Infect. Dis. 15 (Suppl. 1), S216-S227 (1992).
2. Warren, J.W., et al. Guidelines for antimicrobial treatment of uncomplicated acute bacterial cystitis and acute pyelonephritis in womeN. Infectious Diseases Society of America (IDSA). CliN. Infect. Dis. 29, 745-758 (1999). (Pubitemid 30256361)
3. Ferry, S. A., Holm, S. E., Stenlund, H., Lundholm, R. & Monsen, T. J. Clinical and bacteriological outcome of different doses and duration of pivmecillinam compared with placebo therapy of uncomplicated lower urinary tract infection in women: the LUTIW project. Scand. J. Prim. Health Care 25, 49-57 (2007).
4. Nicolle, L. E. Asymptomatic bacteriuria- important or not? N. Engl. J. Med. 343, 1037-1039 (2000).
5. Nicolle, L. E. Infectious Diseases Society of America guidelines for the diagnosis and treatment of asymptomatic bacteriuria in adults. CliN. Infect. Dis. 40, 643-654 (2005). (Pubitemid 40381336)
6. Dethlefsen, L., Huse, S., Sogin, M. L. & Relman, D. A. The pervasive effects of an antibiotic on the human gut microbiota, as revealed by deep 16S rrNA sequencing. PLoS Biol. 6, e280 (2008).
7. Heidler, S., et al. The natural history of lower urinary tract symptoms in females: analysis of a health screening project. EuR. Urol. 52, 1744-1750 (2007). (Pubitemid 350052420)
8. Wollin, T., Laroche, B. & Psooy, K. Canadian guidelines for the management of asymptomatic microscopic hematuria in adults. CaN. Urol. Assoc. J. 3, 77-80 (2009).
9. Tomson, C. & Porter, T. Asymptomatic microscopic or dipstick haematuria in adults: which investigations for which patients? A review of the evidencE. BJU Int. 90, 185-198 (2002). (Pubitemid 34989063)
10. Madeb, R.,et al. Long-term outcome of patients with a negative work-up for asymptomatic microhematuria. Urology 75, 20-25 (2010).
11. Schmiemann, G., Kniehl, E., Gebhardt, K., Matejczyk, M. M. & Hummers-Pradier, E. The diagnosis of urinary tract infection: a systematic revieW. Dtsch Arztebl. Int. 107, 361-367 (2010).
12. Maki, D. G. & Tambyah, P. A. Engineering out the risk for infection with urinary catheters. Emerg. Infect. Dis. 7, 342-347 (2001). (Pubitemid 32374358)
13. Tambyah, P. A. & Maki, D. G. Catheter-associated urinary tract infection is rarely symptomatic: a prospective study of 1,497 catheterized patients. Arch. InterN. Med. 160, 678-682 (2000). (Pubitemid 30140418)
14. Tambyah, P. A. & Maki, D. G. The relationship between pyuria and infection in patients with indwelling urinary catheters: a prospective study of 761 patients. Arch. InterN. Med. 160, 673-677 (2000). (Pubitemid 30140417)
15. Hooton, T.M., et al. Diagnosis, prevention, and treatment of catheter-associated urinary tract infection in adults: 2009 International Clinical Practice Guidelines from the Infectious Diseases Society of America. CliN. Infect. Dis. 50, 625-663 (2010).
16. Stamm, W. E. Scientific and clinical challenges in the management of urinary tract infections. Am. J. Med. 113 (Suppl. 1A), 1S-4S (2002). (Pubitemid 34756639)
17. Mulvey, M. A., Schilling, J. D., Martinez, J. J. & Hultgren, S. J. Bad bugs and beleaguered bladders: interplay between uropathogenic Escherichia coli and innate host defenses. Proc. Natl Acad. ScI. USA 97, 8829-8835 (2000). (Pubitemid 30626633)
18. Laupland, K. B., ross, T., Pitout, J. D., Church, D. L. & Gregson, D. B. Community-onset urinary tract infections: a population-based assessment. Infection 35, 150-153 (2007). (Pubitemid 46932329)
19. Imirzalioglu, C., Hain, T., Chakraborty, T. & Domann, E. Hidden pathogens uncovered: metagenomic analysis of urinary tract infections. Andrologia 40, 66-71 (2008). (Pubitemid 351379675)
20. al-Wali, W., Hamilton-Miller, J. M., Joshi, S. & Brumfitt, W. A case of recurrently sexually transmitted urinary tract infectioN. GenitouriN. Med. 65, 397-398 (1989). (Pubitemid 20028443)
21. Bailey, R. R., Peddie, B. A., Swainson, C. P. & Kirkpatrick, D. Sexual acquisition of urinary tract infection in a maN. Nephron 44, 217-218 (1986). (Pubitemid 16002546)
22. Foxman, B., et al. risk factors for second urinary tract infection among college womeN. Am. J. Epidemiol. 151, 1194-1205 (2000). (Pubitemid 30451952)
23. Foxman, B., et al. Uropathogenic Escherichia coli are more likely than commensal E. coli to be shared between heterosexual sex partners. Am. J. Epidemiol. 156, 1133-1140 (2002). (Pubitemid 35453684)
24. Foxman, B., et al. Condom use and first-time urinary tract infectioN. Epidemiology 8, 637-641 (1997). (Pubitemid 27449494)
25. O'Neill, P. M., Talboys, C. A., roberts, A. P. & Azadian, B. S. The rise and fall of Escherichia coli O15 in a London teaching hospital. J. Med. Microbiol. 33, 23-27 (1990). (Pubitemid 20289844)
26. Peirano, G., et al. High prevalence of ST131 isolates producing CTX-M-15 and CTX-M-14 among extended-spectrum-ß-lactamase-producing Escherichia coli isolates from Canada. Antimicrob. Agents ChemotheR. 54, 1327-1330 (2010).
27. Freeman, J.T., et al. Community-onset genitourinary tract infection due to CTX-M-15- producing Escherichia coli among travelers to the Indian subcontinent in New Zealand. CliN. Infect. Dis. 47, 689-692 (2008).
28. Pitout, J. D. Infections with extended-spectrum ß-lactamase- producing enterobacteriaceae: changing epidemiology and drug treatment choices. Drugs 70, 313-333 (2010).
29. Vincent, C., et al. Food reservoir for Escherichia coli causing urinary tract infections. Emerg. Infect. Dis. 16, 88-95 (2010).
30. Schaberg, D. R., Weinstein, R. A. & Stamm, W. E. Epidemics of nosocomial urinary tract infection caused by multiply resistant Gram-negative bacilli: epidemiology and control. J. Infect. Dis. 133, 363-366 (1976).
31. Huang, W.C., et al. Catheter-associated urinary tract infections in intensive care units can be reduced by prompting physicians to remove unnecessary catheters. Infect. Control Hosp. Epidemiol. 25, 974-978 (2004).
32. Johnson, C. C. Definitions, classification, and clinical presentation of urinary tract infections. Med. CliN. North Am. 75, 241-252 (1991).
33. Foxman, B. & Brown, P. Epidemiology of urinary tract infections: transmission and risk factors, incidence, and costs. Infect. Dis. CliN. North Am. 17, 227-241 (2003). (Pubitemid 36760181)
34. Van der Kooi, T. I., Manniën, J., Wille, J. C. & van Benthem, B. H. Prevalence of nosocomial infections in The Netherlands, 2007-2008: results of the first four national studies. J. Hosp. Infect. 75, 168-172 (2010).
35. Tang, K. K., Wong, C. K., Lo, S. F. & Ng, T. K. Is it necessary to catheterise the bladder routinely before gynaecological laparoscopic surgery? Aust. N. Z. J. Obstet. Gynaecol. 45, 380-383 (2005). (Pubitemid 41830358)
36. Little, P., et al. Presentation, pattern, and natural course of severe symptoms, and role of antibiotics and antibiotic resistance among patients presenting with suspected uncomplicated urinary tract infection in primary care: observational study. BMJ 340, b5633 (2010).
37. Christiaens, T.C., et al. randomised controlled trial of nitrofurantoin versus placebo in the treatment of uncomplicated urinary tract infection in adult womeN. BR. J. GeN. Pract. 52, 729-734 (2002). (Pubitemid 36187595)
38. Katchman, E.A., et al. Three-day vs longer duration of antibiotic treatment for cystitis in women: systematic review and meta-analysis. Am. J. Med. 118, 1196-1207 (2005). (Pubitemid 41566518)
39. Foxman, B., Barlow, R., D'Arcy, H., Gillespie, B. & Sobel, J. D. Urinary tract infection: self-reported incidence and associated costs. AnN. Epidemiol. 10, 509-515 (2000).
40. Saint, S. Clinical and economic consequences of nosocomial catheter-related bacteriuria. Am. J. Infect. Control 28, 68-75 (2000). (Pubitemid 30120943)
41. Hooton, T.M., et al. A prospective study of risk factors for symptomatic urinary tract infection in young womeN. N. Engl. J. Med. 335, 468-474 (1996). (Pubitemid 26269946)
42. Ki, M., Park, T., Choi, B. & Foxman, B. The epidemiology of acute pyelonephritis in South Korea, 1997-1999. Am. J. Epidemiol. 160, 985-993 (2004). (Pubitemid 39488427)
43. Rosen, D. A., Hooton, T. M., Stamm, W. E., Humphrey, P. A. & Hultgren, S. J. Detection of intracellular bacterial communities in human urinary tract infectioN. PLoS Med. 4, e329 (2007).
44. Weichhart, T., Haidinger, M., Hörl, W. H. & Säemann, M. D. Current concepts of molecular defence mechanisms operative during urinary tract infectioN. EuR. J. CliN. Invest. 38 (Suppl. 2), 29-38 (2008).
45. Song, J. & Abraham, S. N. Innate and adaptive immune responses in the urinary tract. EuR. J. CliN. Invest. 38 (Suppl. 2), 21-28 (2008).
46. Stamm, W. E., McKevitt, M., roberts, P. L. & White, N. J. Natural history of recurrent urinary tract infections in womeN. ReV. Infect. Dis. 13, 77-84 (1991).
47. Hawn, T.R., et al. Genetic variation of the human urinary tract innate immune response and asymptomatic bacteriuria in womeN. PLoS ONE 4, e8300 (2009).
48. Lundstedt, A.C., et al. Inherited susceptibility to acute pyelonephritis: a family study of urinary tract infectioN. J. Infect. Dis. 195, 1227-1234 (2007).
49. Hawn, T.R., et al. Toll-like receptor polymorphisms and susceptibility to urinary tract infections in adult womeN. PLoS ONE 4, e5990 (2009).
50. Sheinfeld, J., Schaeffer, A. J., Cordon-Cardo, C., rogatko, A. & Fair, W. R. Association of the Lewis blood-group phenotype with recurrent urinary tract infections in womeN. N. Engl. J. Med. 320, 773-777 (1989). (Pubitemid 19093544)
51. Tempera, G., et al. The impact of prulifloxacin on vaginal lactobacillus microflora: an in vivo study. J. Chemother. 21, 646-650 (2009).
52. Kurtaran, B., et al. Antibiotic resistance in community-acquired urinary tract infections: prevalence and risk factors. Med. ScI. Monit. 16, Cr246-Cr251 (2010).
53. Colodner, R., Kometiani, I., Chazan, B. & Raz, R. risk factors for community-acquired urinary tract infection due to quinolone-resistant E. colI. Infection 36, 41-45 (2008).
54. Sundqvist, M., et al. Little evidence for reversibility of trimethoprim resistance after a drastic reduction in trimethoprim usE. J. Antimicrob. ChemotheR. 65, 350-360 (2010).
55. Schito, G.C., et al. The ArESC study: an international survey on the antimicrobial resistance of pathogens involved in uncomplicated urinary tract infections. Int. J. Antimicrob. Agents 34, 407-413 (2009).
56. Karlowsky, J. A., Kelly, L. J., Thornsberry, C., Jones, M. E. & Sahm, D. F. Trends in antimicrobial resistance among urinary tract infection isolates of Escherichia coli from female outpatients in the United States. Antimicrob. Agents Chemother. 46, 2540-2545 (2002). (Pubitemid 34793461)
57. Zhanel, G.G., et al. Antibiotic resistance in outpatient urinary isolates: final results from the North American Urinary Tract Infection Collaborative Alliance (NAUTICA). Int. J. Antimicrob. Agents 26, 380-388 (2005). (Pubitemid 41483468)
58. Moreira, E. D. Jr et al. Antimicrobial resistance of Escherichia coli strains causing communityacquired urinary tract infections among insured and uninsured populations in a large urban centeR. J. Chemother. 18, 255-260 (2006). (Pubitemid 44098073)
59. Alós, J. I., Serrano, M. G., Gómez-Garcés, J. L. & Perianes, J. Antibiotic resistance of Escherichia coli from community-acquired urinary tract infections in relation to demographic and clinical data. CliN. Microbiol. Infect. 11, 199-203 (2005). (Pubitemid 40352766)
60. DeBusscher, J., Zhang, L., Buxton, M., Foxman, B. & Barbosa-Cesnik, C. Persistent extended-spectrum ß-lactamase urinary tract infectioN. Emerg. Infect. Dis. 15, 1862-1864 (2009).
61. Doi, Y., et al. Community-acquired extendedspectrum ß-lactamase producers, United States. Emerg. Infect. Dis. 13, 1121-1123 (2007). (Pubitemid 47048102)
62. Azap, O.K., et al. risk factors for extendedspectrum ß-lactamase positivity in uropathogenic Escherichia coli isolated from community-acquired urinary tract infections. CliN. Microbiol. Infect. 16, 147-151 (2010).
63. Bleidorn, J., Gágyor, I., Kochen, M. M., Wegscheider, K. & Hummers-Pradier, E. Symptomatic treatment (ibuprofen) or antibiotics (ciprofloxacin) for uncomplicated urinary tract infection? results of a randomized controlled pilot trial. BMC Med. 8, 30 (2010).